Treatment of multiple sclerosis using placental stem cells
US8216566B2 · kind B2 · utility
9Cited by
221References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 14, 2010 |
| Grant date | Jul 10, 2012 |
| Priority date | — |
| Expiry date | Jan 14, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2502/11
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods of immunomodulation using placental stem cells and placental stem cell populations. The invention also provides methods of producing and selecting placental cells and cell populations on the basis of immunomodulation, and compositions comprising such cells and cell populations.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.